Targeting prodrug-activating vectors for selectivecancer therapy
博士 === 高雄醫學大學 === 醫學研究所 === 96 === Increasing the specificity of chemotherapy may improve the efficacy of cancer treatment. Toward this aim, two strategies were designed to specific delivery prodrug activating enzyme (??-glucuronidase) to tumors. One is combination cancer therapy by Hapten-Targeted...
Main Authors: | Chiu-Min Cheng, 鄭秋敏 |
---|---|
Other Authors: | Tian-Lu Cheng |
Format: | Others |
Language: | zh-TW |
Published: |
2008
|
Online Access: | http://ndltd.ncl.edu.tw/handle/01846110593367936379 |
Similar Items
-
Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy
by: Yue Li, et al.
Published: (2021-07-01) -
Targeted enzyme activation of anti-neoplastic prodrugs for therapy of metastasis
by: Show Len Wei, et al.
Published: (1995) -
Development of Glucuronide Trapping Probe for β-Glucuronidase Based Imaging and Prodrug Targeted Therapy
by: Ta-Chun Cheng, et al.
Published: (2012) -
Targeted delivery of polymer prodrug conjugates for cancer therapy
Published: () -
Treatment of cancer with prodrugs activated by antibody targeted enzyme conjugates
by: WANG, XING-MIN, et al.
Published: (1992)